{"product_id":"semaglutide-1mg-1mg-1mg-3-month-bundle","title":"Semaglutide – 3-Month Supply – 503A Compounded","description":"\u003cdiv class=\"relax-consultation-fallback\"\u003e\n\u003cp\u003eAn in-person consultation with a RELAX specialist is required to discuss this product. Availability depends on clinical suitability and any applicable prescription requirements.\u003c\/p\u003e\n\u003cp\u003e\u003ca class=\"button button--secondary\" href=\"tel:+12153451100\"\u003eCall us\u003c\/a\u003e   \u003ca class=\"button\" href=\"https:\/\/booking.mangomint.com\/163230\"\u003eMake an appointment\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/div\u003e\u003ch3\u003e1mg 1mg 1mg\u003c\/h3\u003e\u003cp\u003eA glucagon-like peptide-1 receptor agonist with an albumin-binding fatty acid side chain conferring an extended half-life suitable for weekly administration. Acts on GLP-1 receptors influencing glucose-dependent insulin secretion, glucagon suppression, gastric emptying and central appetite signalling.\u003cbr\u003eSupplied as three already reconstituted, ready-to-use sterile aqueous solution vials of 1 mL, dosed in sequence at 1mg, 1mg and 1mg. No reconstitution or mixing is required before administration. For subcutaneous administration. Dispensed as a 3-month course totalling 84 days of therapy, supplied as the vials listed for the selected strength option.\u003c\/p\u003e\u003ch3\u003e1mg 1mg 2mg\u003c\/h3\u003e\u003cp\u003eA glucagon-like peptide-1 receptor agonist with an albumin-binding fatty acid side chain conferring an extended half-life suitable for weekly administration. Acts on GLP-1 receptors influencing glucose-dependent insulin secretion, glucagon suppression, gastric emptying and central appetite signalling.\u003cbr\u003eSupplied as three already reconstituted, ready-to-use sterile aqueous solution vials of 1 mL, dosed in sequence at 1mg, 1mg and 2mg. No reconstitution or mixing is required before administration. For subcutaneous administration. Dispensed as a 3-month course totalling 84 days of therapy, supplied as the vials listed for the selected strength option.\u003c\/p\u003e\u003ch3\u003e2mg 2mg 2mg\u003c\/h3\u003e\u003cp\u003eA glucagon-like peptide-1 receptor agonist with an albumin-binding fatty acid side chain conferring an extended half-life suitable for weekly administration. Acts on GLP-1 receptors influencing glucose-dependent insulin secretion, glucagon suppression, gastric emptying and central appetite signalling.\u003cbr\u003eSupplied as three already reconstituted, ready-to-use sterile aqueous solution vials of 1 mL, dosed in sequence at 2mg, 2mg and 2mg. No reconstitution or mixing is required before administration. For subcutaneous administration. Dispensed as a 3-month course totalling 84 days of therapy, supplied as the vials listed for the selected strength option.\u003c\/p\u003e\u003ch3\u003e2mg 4mg 4mg\u003c\/h3\u003e\u003cp\u003eA glucagon-like peptide-1 receptor agonist with an albumin-binding fatty acid side chain conferring an extended half-life suitable for weekly administration. Acts on GLP-1 receptors influencing glucose-dependent insulin secretion, glucagon suppression, gastric emptying and central appetite signalling.\u003cbr\u003eSupplied as three already reconstituted, ready-to-use sterile aqueous solution vials of 1 mL, dosed in sequence at 2mg, 4mg and 4mg. No reconstitution or mixing is required before administration. For subcutaneous administration. Dispensed as a 3-month course totalling 84 days of therapy, supplied as the vials listed for the selected strength option.\u003c\/p\u003e\u003ch3\u003e4mg 4mg 4mg\u003c\/h3\u003e\u003cp\u003eA glucagon-like peptide-1 receptor agonist with an albumin-binding fatty acid side chain conferring an extended half-life suitable for weekly administration. Acts on GLP-1 receptors influencing glucose-dependent insulin secretion, glucagon suppression, gastric emptying and central appetite signalling.\u003cbr\u003eSupplied as three already reconstituted, ready-to-use sterile aqueous solution vials of 1 mL, dosed in sequence at 4mg, 4mg and 4mg. No reconstitution or mixing is required before administration. For subcutaneous administration. Dispensed as a 3-month course totalling 84 days of therapy, supplied as the vials listed for the selected strength option.\u003c\/p\u003e\u003ch3\u003e4mg 4mg 6mg\u003c\/h3\u003e\u003cp\u003eA glucagon-like peptide-1 receptor agonist with an albumin-binding fatty acid side chain conferring an extended half-life suitable for weekly administration. Acts on GLP-1 receptors influencing glucose-dependent insulin secretion, glucagon suppression, gastric emptying and central appetite signalling.\u003cbr\u003eSupplied as three already reconstituted, ready-to-use sterile aqueous solution vials of 1 mL, dosed in sequence at 4mg, 4mg and 6mg. No reconstitution or mixing is required before administration. For subcutaneous administration. Dispensed as a 3-month course totalling 84 days of therapy, supplied as the vials listed for the selected strength option.\u003c\/p\u003e\u003ch3\u003eStarter: 1mg, 2mg, 4mg\/mL\u003c\/h3\u003e\u003cp\u003eA glucagon-like peptide-1 receptor agonist with an albumin-binding fatty acid side chain conferring an extended half-life suitable for weekly administration. Acts on GLP-1 receptors influencing glucose-dependent insulin secretion, glucagon suppression, gastric emptying and central appetite signalling.\u003cbr\u003eSupplied as an already reconstituted, ready-to-use sterile aqueous solution in a 1 mL vial at Starter: 1mg, 2mg, 4mg\/mL. No reconstitution or mixing is required before administration. For subcutaneous administration. Dispensed as a 3-month course totalling 84 days of therapy, supplied as the vials listed for the selected strength option.\u003c\/p\u003e\u003ch3\u003e4mg 6mg 6mg\u003c\/h3\u003e\u003cp\u003eA glucagon-like peptide-1 receptor agonist with an albumin-binding fatty acid side chain conferring an extended half-life suitable for weekly administration. Acts on GLP-1 receptors influencing glucose-dependent insulin secretion, glucagon suppression, gastric emptying and central appetite signalling.\u003cbr\u003eSupplied as three already reconstituted, ready-to-use sterile aqueous solution vials of 1 mL, dosed in sequence at 4mg, 6mg and 6mg. No reconstitution or mixing is required before administration. For subcutaneous administration. Dispensed as a 3-month course totalling 84 days of therapy, supplied as the vials listed for the selected strength option.\u003c\/p\u003e\u003ch3\u003e2mg, 4mg, 6mg\u003c\/h3\u003e\u003cp\u003eA glucagon-like peptide-1 receptor agonist with an albumin-binding fatty acid side chain conferring an extended half-life suitable for weekly administration. Acts on GLP-1 receptors influencing glucose-dependent insulin secretion, glucagon suppression, gastric emptying and central appetite signalling.\u003cbr\u003eSupplied as three already reconstituted, ready-to-use sterile aqueous solution vials of 1 mL, dosed in sequence at 2mg, 4mg and 6mg. No reconstitution or mixing is required before administration. For subcutaneous administration. Dispensed as a 3-month course totalling 84 days of therapy, supplied as the vials listed for the selected strength option.\u003c\/p\u003e\u003ch3\u003e6mg, 6mg, 6mg\u003c\/h3\u003e\u003cp\u003eA glucagon-like peptide-1 receptor agonist with an albumin-binding fatty acid side chain conferring an extended half-life suitable for weekly administration. Acts on GLP-1 receptors influencing glucose-dependent insulin secretion, glucagon suppression, gastric emptying and central appetite signalling.\u003cbr\u003eSupplied as three already reconstituted, ready-to-use sterile aqueous solution vials of 1 mL, dosed in sequence at 6mg, 6mg and 6mg. No reconstitution or mixing is required before administration. For subcutaneous administration. Dispensed as a 3-month course totalling 84 days of therapy, supplied as the vials listed for the selected strength option.\u003c\/p\u003e\u003ch3\u003e6mg 6mg 10mg\u003c\/h3\u003e\u003cp\u003eA glucagon-like peptide-1 receptor agonist with an albumin-binding fatty acid side chain conferring an extended half-life suitable for weekly administration. Acts on GLP-1 receptors influencing glucose-dependent insulin secretion, glucagon suppression, gastric emptying and central appetite signalling.\u003cbr\u003eSupplied as three already reconstituted, ready-to-use sterile aqueous solution vials of 1 mL, dosed in sequence at 6mg, 6mg and 10mg. No reconstitution or mixing is required before administration. For subcutaneous administration. Dispensed as a 3-month course totalling 84 days of therapy, supplied as the vials listed for the selected strength option.\u003c\/p\u003e\u003ch3\u003e4mg, 6mg, 10mg\u003c\/h3\u003e\u003cp\u003eA glucagon-like peptide-1 receptor agonist with an albumin-binding fatty acid side chain conferring an extended half-life suitable for weekly administration. Acts on GLP-1 receptors influencing glucose-dependent insulin secretion, glucagon suppression, gastric emptying and central appetite signalling.\u003cbr\u003eSupplied as three already reconstituted, ready-to-use sterile aqueous solution vials of 1 mL, dosed in sequence at 4mg, 6mg and 10mg. No reconstitution or mixing is required before administration. For subcutaneous administration. Dispensed as a 3-month course totalling 84 days of therapy, supplied as the vials listed for the selected strength option.\u003c\/p\u003e\u003ch3\u003e6mg 10mg 10mg\u003c\/h3\u003e\u003cp\u003eA glucagon-like peptide-1 receptor agonist with an albumin-binding fatty acid side chain conferring an extended half-life suitable for weekly administration. Acts on GLP-1 receptors influencing glucose-dependent insulin secretion, glucagon suppression, gastric emptying and central appetite signalling.\u003cbr\u003eSupplied as three already reconstituted, ready-to-use sterile aqueous solution vials of 1 mL, dosed in sequence at 6mg, 10mg and 10mg. No reconstitution or mixing is required before administration. For subcutaneous administration. Dispensed as a 3-month course totalling 84 days of therapy, supplied as the vials listed for the selected strength option.\u003c\/p\u003e\u003ch3\u003eMaintenance: 10mg, 10mg, 10mg\u003c\/h3\u003e\u003cp\u003eA glucagon-like peptide-1 receptor agonist with an albumin-binding fatty acid side chain conferring an extended half-life suitable for weekly administration. Acts on GLP-1 receptors influencing glucose-dependent insulin secretion, glucagon suppression, gastric emptying and central appetite signalling.\u003cbr\u003eSupplied as three already reconstituted, ready-to-use sterile aqueous solution vials of 1 mL, dosed in sequence at 10mg, 10mg and 10mg. No reconstitution or mixing is required before administration. For subcutaneous administration. Dispensed as a 3-month course totalling 84 days of therapy, supplied as the vials listed for the selected strength option.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eVial size listed by supplier\u003c\/strong\u003e 1 mL\u003c\/p\u003e\u003cp class=\"relax-supplier-availability\"\u003e\u003cstrong\u003eSupplier availability\u003c\/strong\u003e · In stock\u003c\/p\u003e\u003cdiv class=\"relax-native-related\"\u003e\n\u003ch2\u003eSimilar products\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"\/products\/semaglutide-1mg-ml\"\u003eSemaglutide – 1-Month Supply – 503A Compounded\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"\/products\/tirzepatide-5mg-5mg-5mg-3-month-bundle\"\u003eTirzepatide – 3-Month Supply – 503A Compounded\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e","brand":"ProPepMD","offers":[{"title":"1mg 1mg 1mg \/ 1 mL","offer_id":50984992145601,"sku":"RXR-310B0939-dmp-sema-3-month-injection-1mg1mg1mg","price":176.0,"currency_code":"USD","in_stock":true},{"title":"1mg 1mg 2mg \/ 1 mL","offer_id":50984992178369,"sku":"RXR-6B72201A-dmp-sema-3-month-injection-1mg1mg2mg","price":220.0,"currency_code":"USD","in_stock":true},{"title":"2mg 2mg 2mg \/ 1 mL","offer_id":50984992211137,"sku":"RXR-6D13A8DC-dmp-sema-3-month-injection-2mg2mg2mg","price":237.6,"currency_code":"USD","in_stock":true},{"title":"2mg 4mg 4mg \/ 1 mL","offer_id":50984992243905,"sku":"RXR-416BDAD7-dmp-sema-3-month-injection-2mg4mg4mg","price":281.6,"currency_code":"USD","in_stock":true},{"title":"4mg 4mg 4mg \/ 1 mL","offer_id":50984992276673,"sku":"RXR-D3142356-dmp-sema-3-month-injection-4mg4mg4mg","price":308.0,"currency_code":"USD","in_stock":true},{"title":"4mg 4mg 6mg \/ 1 mL","offer_id":50984992309441,"sku":"RXR-91788CA3-dmp-semaglutide-3-mth-starter-kit-1mg-2m","price":352.0,"currency_code":"USD","in_stock":true},{"title":"Starter: 1mg, 2mg, 4mg\/mL \/ 1 mL","offer_id":50984992342209,"sku":"RXR-FC316E64-dmp-sema-3-month-injection-4mg4mg6mg","price":352.0,"currency_code":"USD","in_stock":true},{"title":"4mg 6mg 6mg \/ 1 mL","offer_id":50984992374977,"sku":"RXR-022B9776-dmp-sema-3-month-injection-4mg6mg6mg","price":396.0,"currency_code":"USD","in_stock":true},{"title":"2mg, 4mg, 6mg \/ 1 mL","offer_id":50984992407745,"sku":"RXR-01D275D2-dmp-sema-2mg4mg6mg","price":413.6,"currency_code":"USD","in_stock":true},{"title":"6mg, 6mg, 6mg \/ 1 mL","offer_id":50984992440513,"sku":"RXR-351463BF-dmp-sema-6mg-x-3-vials","price":431.2,"currency_code":"USD","in_stock":true},{"title":"6mg 6mg 10mg \/ 1 mL","offer_id":50984992473281,"sku":"RXR-D8CA9842-dmp-sema-4mg6mg10mg","price":466.4,"currency_code":"USD","in_stock":true},{"title":"4mg, 6mg, 10mg \/ 1 mL","offer_id":50984992506049,"sku":"RXR-CEC50B1C-dmp-sema-3-month-injection-6mg6mg10mg","price":466.4,"currency_code":"USD","in_stock":true},{"title":"6mg 10mg 10mg \/ 1 mL","offer_id":50984992538817,"sku":"RXR-2A076DEB-dmp-sema-3-month-injection-6mg10mg10mg","price":501.6,"currency_code":"USD","in_stock":true},{"title":"Maintenance: 10mg, 10mg, 10mg \/ 1 mL","offer_id":50984992571585,"sku":"RXR-19003C8E-dmp-sema-maintenance-10mg-x-3-vials","price":519.2,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0809\/7490\/5537\/files\/propepmd-semaglutide-1mg-1mg-1mg-3-month-bundle-1.png?v=1795066818","url":"https:\/\/belladermabocaspa.com\/products\/semaglutide-1mg-1mg-1mg-3-month-bundle","provider":"Bella Derma Boca Spa","version":"1.0","type":"link"}